Startups
AMADTEUS Technologies
AMADTEUS Technologies develops miniaturised and automated chemistry platforms for early drug discovery. It combines high-throughput synthesis and screening, acoustic nanolitre dispensing, multicomponent chemistry and computational methods to explore libraries of potential bioactive molecules while reducing reagent use and manual experimentation. The Hamburg company is a spin-off associated with Palacký University Olomouc and was co-founded within the IP Lab Ventures ecosystem. It has partnered with Accelerated Muscle Biotechnologies and Sarcometrics to apply accelerated discovery to cardiac and skeletal muscle therapies and supplements.
Team
Investments
No investment rounds on record yet.